The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

August 13, 2022

Study Completion Date

August 13, 2022

Conditions

Acute Infectious Conjunctivitis (Disorder)

Interventions

DRUG

SCH-1

Novel anti-infective eyedrop

DRUG

Placebo

SCH-1 vehicle minus active components eyedrop

Trial Locations (1)

Jacqueline Dauhajre, MD, Jackson Heights

All Listed Sponsors

lead

Sacsh

INDUSTRY

NCT05356793 - The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis | Biotech Hunter | Biotech Hunter